Published in

Oxford University Press (OUP), Journal of Clinical Endocrinology and Metabolism, 2020

DOI: 10.1210/clinem/dgaa359

Links

Tools

Export citation

Search in Google Scholar

Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: a Controlled Dietary Intervention Study

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Context Although dietary potassium and sodium intake may influence calcium-phosphate metabolism, and bone health, the effects on bone mineral parameters, including fibroblast growth factor 23 (FGF23) are unclear. Objective Here, we investigated the effects of potassium or sodium supplementation on bone mineral parameters. Design setting, participants: We performed a post-hoc analysis of a dietary controlled randomized, blinded, placebo-controlled crossover trial. Pre-hypertensive individuals not using antihypertensive medication (n=36) received capsules containing potassium chloride (3 grams/day), sodium chloride (3 grams/day) or placebo. Linear mixed-effect models were used to estimate treatment effects. Results Potassium supplementation increased plasma phosphate (from 1.10±0.19 to 1.15±0.19 mmol/L, P=0.004), in line with increase in tubular maximum of phosphate reabsorption (TmP/GFR; from 0.93±0.21 to 1.01±0.20 mmol/L, P<0.001). FGF23 decreased (114.3 [96.8-135.0] to 108.5 [93.5-125.9] RU/mL, [P=0.01]), without change in parathyroid hormone and 25(OH)-vitamin D3. Fractional calcium excretion decreased (from 1.25±0.50 to 1.11±0.46 %, P=0.03) without change in plasma calcium. Sodium supplementation decreased both plasma phosphate (from 1.10±0.19 to 1.06±0.21 mmol/L, P=0.03) and FGF23 (from 114.3 [96.8-135.0] to 108.7 [92.3-128.1] RU/mL, P=0.02). Urinary and fractional calcium excretion increased (from 4.28±1.91 to 5.45±2.51 mmol/24 hrs, P<0.001, and from 1.25±0.50 to 1.44±0.54 %, P=0.004, respectively). Conclusions Potassium supplementation led to a decrease in FGF23, which was accompanied by increase in plasma phosphate and decreased calcium excretion. Sodium supplementation reduced FGF23, but this was accompanied by decrease in phosphate and increase in fractional calcium excretion. Our results indicate distinct effects of potassium and sodium intake on bone mineral parameters, including FGF23.